The company said net sales for Q2 (3 months) were $2,161 million, up 3.9% from $2,081 million a year earlier, and organic sales growth was 2.8%.

1. 01

   The company said net sales for Q2 (3 months) were $2,161 million, up 3.9% from $2,081 million a year earlier, and organic sales growth was 2.8%.

2. 02

   Solventum said its operating income margin for Q2 was 9.9%, down 180 basis points from 11.7% a year earlier, and its adjusted operating income margin was 21.9%. Solventum cited lower gross margins, including the impact of the 3M supply agreement mark-up, and higher operating expenses from public company stand-up costs and growth investments as factors behind the decline.

3. 03

   Solventum said operating cash flow for Q2 was $169 million and free cash flow was $59 million. Operating cash flow for the 6 months was $198 million, and free cash flow was $(21) million.

4. 04

   Solventum said it raised its full-year organic sales growth outlook to +2.0% to +3.0% from the prior range of +1.5% to +2.5%, and raised its adjusted EPS outlook to $5.80 to $5.95 from $5.45 to $5.65. Its free cash flow outlook of $450M to $550M was unchanged.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.